PHASE-I EVALUATION OF ORAL BCX-34 (PELDESINE) IN CUTANEOUS T-CELL LYMPHOMA (CTCL)

Citation
Mn. Saleh et al., PHASE-I EVALUATION OF ORAL BCX-34 (PELDESINE) IN CUTANEOUS T-CELL LYMPHOMA (CTCL), Blood, 88(10), 1996, pp. 2277-2277
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
1
Supplement
1
Pages
2277 - 2277
Database
ISI
SICI code
0006-4971(1996)88:10<2277:PEOOB(>2.0.ZU;2-3